NASDAQ:IMVT

Immunovant Stock Insider Trading

etoro logo Buy IMVT
*Your capital is at risk
$37.62
-0.480 (-1.26%)
At Close: Jun 23, 2026

Immunovant Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 90.46. In total, the insiders bought 26.23M and sold 735.97K IMVT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
90.46
Buy 26.23M shares
Sell 735.97K shares
53% Buy Activity
Moderate Negative Correlation
Sell Signal Low Confidence
May 28, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 90.46.
  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Apr 02, 2026
Sell
Common Stock
S-Sale
Venker Eric
Chief Executive Officer
CEO / President 1 409
Value: $34.7K
Apr 01, 2026
Buy
Capped Value Appreciation Rights
M-Exempt
Venker Eric
Chief Executive Officer
CEO / President 368 750
Value: $5.33M
Apr 01, 2026
Buy
Common Stock
M-Exempt
Venker Eric
Chief Executive Officer
CEO / President 368 750
Value: $5.33M
Apr 01, 2026
Sell
Common Stock
D-Return
Venker Eric
Chief Executive Officer
CEO / President 334 960
Value: $8.41M
Mar 18, 2026
Sell
Common Stock
S-Sale
Van Tuyl Christopher
Chief Legal Officer
Officer 2 877
Value: $71.8K
Feb 25, 2026
Sell
Common Stock
S-Sale
Gloria Melanie
Chief Operating Officer
C-Suite Officer 859
Value: $24.2K
Feb 25, 2026
Sell
Common Stock
S-Sale
Gloria Melanie
Chief Operating Officer
C-Suite Officer 1 437
Value: $38.8K
Feb 25, 2026
Sell
Common Stock
S-Sale
Gloria Melanie
Chief Operating Officer
C-Suite Officer 942
Value: $27.2K
Jan 21, 2026
Sell
Common Stock
S-Sale
Stout Jay S
Chief Technology Officer
Officer 1 977
Value: $51.5K
Jan 07, 2026
Sell
Common Stock
S-Sale
Stout Jay S
Chief Technology Officer
Officer 55
Value: $1K
Jan 07, 2026
Sell
Common Stock
S-Sale
Stout Jay S
Chief Technology Officer
Officer 1 148
Value: $30.4K
Dec 18, 2025
Sell
Common Stock
S-Sale
Van Tuyl Christopher
Chief Legal Officer
Officer 2 284
Value: $62.5K
Dec 18, 2025
Sell
Common Stock
S-Sale
Van Tuyl Christopher
Chief Legal Officer
Officer 8 529
Value: $228.4K
Dec 12, 2025
Buy
Common Stock, $0.0001 par value per share
P-Purchase
Roivant Sciences Ltd.
Director 16 666 666
Value: $0.35B
Dec 01, 2025
Sell
Common Stock
S-Sale
Hughes Douglas J.
Director
Director 13 091
Value: $302.9K
Dec 01, 2025
Sell
Common Stock
S-Sale
Fromkin Andrew J.
Director
Director 2 898
Value: $69.4K
Dec 01, 2025
Sell
Common Stock
S-Sale
Fromkin Andrew J.
Director
Director 19 351
Value: $447.8K
Dec 01, 2025
Sell
Common Stock
S-Sale
Hughes Douglas J.
Director
Director 1 909
Value: $45.7K
Nov 20, 2025
Sell
Common Stock
S-Sale
Gloria Melanie
Chief Operating Officer
C-Suite Officer 10 251
Value: $241.3K
Nov 20, 2025
Sell
Common Stock
S-Sale
Gloria Melanie
Chief Operating Officer
C-Suite Officer 2 375
Value: $56.9K
Oct 22, 2025
Sell
Common Stock
S-Sale
Geffner Michael
Chief Medical Officer
Officer 2 595
Value: $49.4K
Oct 22, 2025
Sell
Common Stock
S-Sale
Stout Jay S
Chief Technology Officer
Officer 2 520
Value: $48.0K
Oct 08, 2025
Sell
Common Stock
S-Sale
Stout Jay S
Chief Technology Officer
Officer 1 585
Value: $25.8K
Oct 08, 2025
Sell
Common Stock
S-Sale
Geffner Michael
Chief Medical Officer
Officer 1 272
Value: $20.7K
Oct 08, 2025
Sell
Common Stock
S-Sale
Stout Jay S
Chief Technology Officer
Officer 1 585
Value: $25.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT IMMUNOVANT, INC.
Immunovant
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE